Carolina Breast Cancer Study: Improving Outcomes Through Communication and Self-Advocacy
This study, called the Carolina Breast Cancer Study (CBCS4), is looking at how different factors – biological (like genetics), clinical (like treatments), and behavioral (like how you talk to your doctors) – affect breast cancer outcomes. It's testing a "structured behavioral intervention" to help you communicate better with your healthcare providers and advocate for yourself during breast cancer care. The study aims to enroll 3300 women, aged 20 to 74, who have invasive breast cancer and live in 59 counties in North Carolina. Success will be measured by changes in your patient communication self-efficacy score (how confident you feel communicating with your doctors) over time. The current recruitment status is unclear.
- Study design
- This interventional study plans to enroll 3300 participants. All participants will receive a structured behavioral intervention.
- What's involved
- You will complete an in-person baseline interview and follow-up surveys. Blood and/or saliva samples will be collected, and you will consent to medical record abstraction and tumor block retrieval.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your patient communication self-efficacy score will be measured at baseline, 19 months, and then every 12-24 months for up to 15 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Patient Communication Self-Efficacy ScoreBaseline, 19 months, every 12-24 months up to 15 years
Patient communication self-efficacy will be measured using the Patient's Communication Perceived Self-Efficacy Scale (PCSS), a validated patient-reported instrument comprising 16 items with a three-factor structure: Provide and Collect Information, Express Concerns and Doubts, and Verify Information. The scale assesses patients' confidence in their ability to communicate effectively with healthcare providers about health concerns, ask questions, express uncertainties, and confirm their understanding. Items are rated on a 5-point Likert scale (1 = not at all confident to 5 = very confident), with total scores ranging from 16 to 80. Higher scores indicate greater perceived communication self-efficacy.